Category 1: Medical CEO Patient Scripts · Episode 02
GLP-1 Prior Authorization Denied? Use This Appeal Script
Clinical Answer Capsule: To overturn a denied GLP-1 prior authorization, appeal citing AMA Resolution 420 - which classifies obesity as a multi-metabolic chronic disease - and request an expedited peer-to-peer review with the insurer's medical director. Documenting specific clinical contraindications for mandated step-therapy drugs (such as phentermine) legally bypasses fail-first requirements.
Prior Authorization (PA)AMA Resolution 420Step-Therapy BypassPeer-to-Peer ReviewClinical Contraindication CodesMedical Necessity
Executive Action Script
"Under AMA Resolution 420 classifying obesity as a multi-metabolic disease, I request an expedited peer-to-peer review with your medical director and formal documentation of contraindications regarding mandated step-therapy."
Full Video Dialogue & Clinical Context
Getting a GLP-1 prior auth rejection feels like a slap in the face, but insurance companies are literally banking on you giving up. Do not let them off the hook. When you appeal, cite AMA Resolution 420 and demand a peer-to-peer review between your doctor and their medical director. Force them to document actual clinical contraindications for why cheaper step-therapy drugs are unsafe for your body. You aren't begging for permission; you are enforcing your contract. Grab the full prior auth appeal template inside the Sovereign GLP-1 Armory at bitchesandbesties.com/armory.
🔬 Verified Clinical Reference:
American Medical Association (AMA) Resolution 420 (A-13): Recognition of Obesity as a Disease. / Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021; 384:989-1002. PMID: 33715155
Access Study: https://pubmed.ncbi.nlm.nih.gov/33715155/
American Medical Association (AMA) Resolution 420 (A-13): Recognition of Obesity as a Disease. / Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021; 384:989-1002. PMID: 33715155
Access Study: https://pubmed.ncbi.nlm.nih.gov/33715155/
Featured Armory Instrument
Tool 01: The PA Power-Up (Prior Authorization & Appeals Arsenal)
Complete fillable 2-page PA submission packet, step-therapy contraindication bypass codes, and continuity-of-care appeals framework.
Unlock Free Instrument in The Armory →